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ABSTRACT 
 
 
Annotation of the Daphnia pulex nuclear receptors revealed a novel group of three 
receptors designated NR1L, and named HR97a/b/g because of their similarity to the 
HR96 receptors involved in xenobiotic detection. We cloned and sequenced the three 
receptors from a related species often used in aquatic toxicology studies, Daphnia magna, 
and then analyzed their genomic structure and conducted phylogenetic studies. 
Phylogenetic studies confirmed that the HR97s do form a distinct group with HR97g 
being the precursor of HR97a and b. They also confirmed that the HR97 receptors are 
related to the HR96 (NR1J) receptors, and the VDR/CAR/PXR (NR1I) group. Mining 
other arthropod genomes revealed that Ixodes also has a NR1L member (IsHR97). Gal4-
chimeric plasmids that contain the ligand binding domain of HR97a/b/g were constructed 
for transactivation assays. Transactivation assays demonstrated that HR97a and HR97g 
repress basal transcription in the absence of a activator; however, HR97b has constitutive 
activity. We hypothesized that the HR97’s are involved in xenobiotic detoxification.  
Contrary to our hypothesis, the HR97s are not activated by multiple toxicants. We found 
that pyriproxyfen and methyl farnesoate activate HR97g. Dose-response studies found 
that pyriproxyfen and methyl farnesoate have EC50’s of 3.4 and 2.2 uM, respectively. 
The two chemicals are juvenile hormone analogs that have been found to induce the 
production of males in the otherwise female parthenogenic Daphnia. HR97a and b are 
also activated by pyriproxyfen. Further, although NR1L is phylogenetically related to 
NR1I and NR1J, the HR97s do not share significant similarity with the NR1I and NR1J 
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members. We conclude that HR97s are not xenobiotic sensors, but may be involved in 
juvenile hormone signaling and potentially male production.  
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CHAPTER ONE 
 
BACKGROUND 
 
The multi-level regulation of gene expression has become the center of modern molecular 
biology, providing insights into physiology, pathology and developmental biology 
(Evans, 2005). In this regulatory process, lipophilic hormones which act as ideal 
messengers, pass the phospholipid bilayer of the cell membrane and interact with proteins 
within the cells (Mangelsdorf et al., 1995). The development of radiolabeled ligands 
demonstrated that these hormones bind to protein receptors and translocate from the 
cytoplasm to the nucleus, suggesting their function in transcriptional regulation (Jensen et 
al., 1966). Later steroids were found to target certain tissues with the presence of high 
affinity receptor proteins and hormonally responsive genes were identified within these 
tissues (Yamamoto, 1985). These studies provided the classic model of steroid hormone 
action where the binding of hormonal ligands to a receptor induces a conformational 
change that allows the ligand-receptor complex to bind to the response element of a gene 
and regulate transcription. 
 
After the cloning of the glucocorticoid receptor (Hollenberg et al., 1985), estrogen 
receptor (Green et al., 1986) and thyroid hormone receptor (Sap et al., 1986), in 1987 the 
discovery of the retinoic acid receptor confirmed the idea of a nuclear receptor 
superfamily (Giguere, Ong, Segui, & Evans, 1987; Petkovich, Brand, Krust, & Chambon, 
1987). Since then, new receptors for known hormones as well as orphan receptors with 
ligands yet to be identified have been constantly added to the nuclear receptor 
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superfamily with the various sequencing and annotation projects, providing valuable 
information on transcriptional regulation and evolution of the animal kingdom (Evans, 
2005). The known nuclear receptors can be divided into seven subfamilies (Nuclear 
Receptors Nomenclature Committee, 1999) with diverse functions ranging from 
embryonic development, reproduction,  nutrient allocation, detoxification, and in general 
the maintenance of homeostasis  (Benoit et al., 2006; Evans, 2005; Mota, Hernandez, & 
Baldwin, 2010). 
 
 
 
Figure 1.1 Five-domain structure of a nuclear receptor. At the N-terminal is the A/B 
domain that functions in ligand-independent transcriptional activation (AF-1). C is the 
DNA binding domain. D is the hinge domain. E is the ligand binding domain and has a 
ligand-dependent activation function (AF-2). At the C-terminal is the F domain. 
 
 
Nuclear receptors share a distinct five-domain structure (Laudet & Gronemeyer, 2002) 
(Figure 1.1). At the N-terminus is the A/B domain that functions in ligand-independent 
transcriptional activation (AF-1), meaning this is where the coactivators can bind in order 
to activate the basal transcriptional complex. The C domain, featuring two Cys rich Zinc 
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finger motifs in tandem, is the DNA binding domain (DBD), which targets the specific 
DNA sequences known as the response elements.  The C domain is involved in both 
DNA binding and dimerization as one zinc finger recognizes the half-site in the response 
element and the other zinc finger functions in homodimerization or heterodimerization. 
The nuclear receptor RXR is a common heterodimerization partner (Benoit et al., 2006). 
The D domain is the hinge domain between the C and E domains. This hinge region adds 
to the protein flexibility thus makes possible the simultaneous receptor dimerization and 
DNA binding. The E domain is the ligand binding domain (LBD). Binding of a ligand, 
which is usually a small lipophilic compound (Kozlova, Lam, & Thummel, 2009), leads 
to the dissociation of co-repressors and recruitment of co-activator proteins. The E 
domain also mediates dimerization and has a ligand-dependent activation function (AF-
2). The AF-2 site interacts with the LXXLL motif (where X can be any amino acid) in 
co-regulators (Centenera, Harris, Tilley, & Butler, 2008). The F domain is not present in 
all nuclear receptors and is highly diverse. Its functional significance is not fully 
understood.  
 
The binding of nuclear receptors and co-regulators to the response elements can either 
regulate the recruitment of RNA polymerase II or stimulates the phosphorylation of pre-
loaded RNA polymerase II. Co-regulators can be enzymes that modify histones and other 
transcription factors, or build links to histone acetylases and other enzymes to the 
receptors (Kininis & Kraus, 2008) (Figure 1.2). 
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Figure 1.2 Regulation of transcription by nuclear receptors. Nuclear receptors usually 
form homo- or heterodimers and recognize the response elements. In the absence of a 
ligand the nuclear receptors could be bound by co-repressors that recruit multiple histone 
deacetylases to the gene, resulting in a compact chromatin that cannot be transcribed. 
Ligand (•) binding releases the co-repressors and recruites co-activators that could be 
histone acetyl transferases or chromatin remodelers and leads to transcription. 
 
Of the five domains, the C and E domains are the most conserved domains of nuclear 
receptors. The domain swap technique, where the LBD of a receptor is linked to the DBD 
of a known receptor, makes it possible for researchers to screen for ligands by activation 
of a target gene while the physiologic functions of a receptor is still unknown (Eads, 
Andrews, & Colbourne, 2008).  The first set of domain swap experiments also 
demonstrated the function of the conserved C and E domains (Giguere et al., 1987; 
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Petkovich et al., 1987). The domain swap technique commonly used nowadays involves 
linking the LBD of a receptor in frame to the DNA binding domain of GAL4. The 
reporter plasmid usually contains the GAL4 response element UAS (Upstream Activation 
Aequence) followed by the luciferase gene. Thus, transcriptional activation can be 
detected through luminescence with the aid of luciferase substrate (Baker, Warren, 
Thummel, Gilbert, & Mangelsdorf, 2000) (Figure 1.3) 
 
 
 
 
Figure 1.3 Illustration of the domain swap technique. The chimeric plasmid is 
constructed by linking the LBD of a receptor in frame to the DNA binding domain of 
GAL4. This plasmid expresses the chimeric protein that contains the GAL4 DBD and 
nuclear receptor LBD. The reporter plasmid contains the GAL4 response element UAS 
followed by the luciferase gene. And transcriptional activation could be detected through 
luminescence with the aid of luciferase substrate. 
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The cladoceran crustacean Daphnia magna, commonly known as the water flea, is a 
crucial component of the aquatic food web because it is a major prey object for fish and 
invertebrate predators. It is also important in water quality control because of its feeding 
on algae (Tatarazako & Oda, 2007).  Daphnids have several well-known stress responses, 
such as the formation of neckteeth in response to predator kairomone (Laforsch et al., 
2004), hemoglobin synthesis in response to oxygen deprivation (Gorr, 2004), male 
production in response to specific unfavorable environments (Tatarazako & Oda, 2007) 
such as overcrowding, changes in photoperiod, poor food quality, and the presence of 
juvenile hormone analogs (Eads et al., 2008). 
 
Daphnia magna is best known for its use as an aquatic toxicology test organism. In part, 
it is often used a bioindicator species and in aquatic toxicology tests because it is 
amenable to culture and inexpensive to use. In turn, eight percent of ECOTOX data for 
aquatic organisms are from Daphnia magna 
(http://daphnia.cgb.indiana.edu/people/news/47) making Daphnia species the most 
popular organisms for testing the toxicity of common aquatic pollutants.   
 
Although the ecology of Daphnia magna is well understood, genomic studies on this 
organism have only recently been started. While the Daphnia magna genome project is 
currently underway, the genome sequencing project of Daphnia pulex, a related 
cladoceran species, has been recently completed, making Daphnia the first aquatic 
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arthropod and the first crustacean fully sequenced (Colbourne et al., 2011).  This provides 
biologists with greater tools with which to study evolution of arthropods and how 
Daphnia deal with environmental stressors, including seasonal changes, food allocation, 
aquatic toxicants, and to determine the mechanisms that guides the development of 
Daphnia through their life cycle; of which male production is a long unsolved puzzle 
(Eads et al., 2008).  
 
Daphnia magna is a cyclical parthenogen. When resources are abundant, female 
daphnids asexually produce female offspring. Under environmental changes, such as 
shorter day length, food depletion, and overcrowding, females produce male daphnids 
and the population switch to sexual reproduction (Tatarazako & Oda, 2007). It has been 
proved that the sesquiterpenoid hormone methyl farnesoate, the unepoxidated form of 
insect Juvenile Hormone III, induces the production of male broods in Daphnia magna 
(Olmstead & Leblanc, 2002). The juvenile hormone analog pyriproxyfen has been shown 
to induce male broods with even higher potency (Tatarazako, Oda, Watanabe, Morita, & 
Iguchi, 2003). However the molecular events behind these observations are still unclear. 
 
Phylogenetic comparisons of the nuclear receptors from Daphnia pulex to other species, 
indicate that Daphnia have a novel group of three nuclear receptors putatively placed in 
the newly formed NR1L group. We named them HR97a, HR97b, and HR97g because of 
their similarity to the NR1J group of nuclear receptors that includes HR96 found in 
Daphnia pulex and Drosophila melanogaster. The phylogenetic data suggest that HR97g 
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is the evolutionary precursor to the other two HR97 receptors that are found in tandem 
repeat (Thomson et al., 2009). 
 
While the function of the NR1L group is unknown, the similarity of these receptors to 
HR96 and the NR1I subfamily (HsVDR, HsCAR, HsPXR) suggests that this group might 
play a role in the regulation of metabolic enzymes involved in the metabolism of 
xenobiotics or endobiotics. The fact that this group exists in crustaceans but not insects 
suggests the possibility of a unique pathway of detoxification in crustaceans, or an 
endocrine process unique to crustaceans.  
 
The goal of this study is to determine potential activators for the HR97 receptors.  The 
objectives of this study are: 
 
Objective 1: Cloning, sequencing, and characterization of magnaHR97g 
The aim of objective 1 is to clone and sequence HR97g from Daphnia magna, compare it 
to Daphnia pulex, and identify potential activators for magnaHR97g.  We hypothesize 
that HR97g from Daphnia magna will have similar sequence identity and genomic 
structure to Daphnia pulex HR97g.  Furthermore, we hypothesize that HR97g is activated 
by multiple toxicants because previous studies showed that it is related to the multi-
toxicant sensors HR96, CAR, and PXR.   
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We will amplify fragments of magnaHR97g by regular PCR using short primers designed 
based on the DappuHR97g sequence and RACE PCR. After sequencing the PCR 
products we will clone the whole magnaHR97g into pCR 2.1 vector using TA cloning. 
Phylogenetic studies will be conducted to confirm its evolutionary history and relatedness 
to the HR96 receptors. Then we will construct a chimeric pBIND-GAL4-97gDEF 
plasmid with the D, E and F domains of magnaHR97g linked in frame to the GAL4 DNA 
binding domain. This plasmid will express the chimeric protein consisting of the GAL4 
DNA binding domain and the magnaHR97g D, E and F domains. This plasmid will be 
used in transactivation assays in combination with the reporter plasmid pG5luc which 
contains five GAL4 binding sites upstream of the firefly luciferase gene. Transactivation 
assays are to be conducted to measure HR97g activity under different conditions and in 
the presence of different chemicals. Lastly, the dose-dependent induction of 
magnaHR97g will be measured following treatment with different concentrations of 
putative activators.   
 
Objective 2:  Cloning, sequencing, and characterization of magnaHR97a and HR97b. 
The aim of objective 2 is to clone and sequence the two duplicated HR97 receptors from 
Daphnia magna, HR97a and HR97b, that are found in tandem repeat.  Potential 
activators will be identified using a transactivation assay.  We hypothesize that HR97a 
and HR97b from Daphnia magna will have similar sequence identity and genomic 
structure to Daphnia pulex HR97a/b.  Furthermore, we hypothesize that these nuclear 
receptors are activated by multiple toxicants because previous studies showed that they 
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are related to the multi-toxicant sensors HR96, CAR, and PXR.  Daphnia pulex is the 
first aquatic arthropod sequenced.  Daphnia contain considerably more genes that 
Drosophila melanogaster or even Homo sapiens, and we consider it likely that the 
amplification of genes was necessary for adapting to an ever changing aquatic 
environment that contains and harbors multiple toxins and toxicants.  Therefore, multiple 
receptors may be needed.      
 
Fragments of magnaHR97a/b will be amplified through regular PCR and RACE PCR. 
After sequencing the PCR products, we will clone the whole magnaHR97a and b 
receptors into pCR 2.1 vectors using TA cloning. The genomic structure of 
magnaHR97a/b will be determined and compared to DappuHR97a/b. Then we will 
construct  chimeric pBIND-GAL4-97a/bDEF plasmids with the D, E and F domains of 
magnaHR97a/b linked in frame to the GAL4 DNA binding domain and carry out 
transactivation assays in combination with the reporter plasmid pG5luc. Transactivation 
assays are to be conducted to measure magnaHR97a/b activity under different conditions 
and in the presence of different chemicals. Dose-response studies will be carried out with 
different concentrations of putative HR97a/b activators.   
 
The characterization of the three novel nuclear receptors in Daphnia magna has two 
purposes. First, it will broaden our current knowledge of nuclear receptor functions and 
evolution. Second, it will reveal some new molecular basis for Daphnia physiology, 
potentially providing novel genetic support to some long-established toxicity tests.  
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CHAPTER TWO 
 
HR97G: A NOVEL NUCLEAR RECEPTOR ACTIVATED BY JUVENILE 
HORMONE ANALOGS 
 
 
ABSTRACT  
The recently sequenced Daphnia pulex genome revealed three novel nuclear receptors 
related to the CAR/PXR/VDR group and were named HR97a/b/g. We cloned HR97g 
from Daphnia magna, a commonly used sentinel species in toxicity testing, and 
constructed a Gal4-chimeric nuclear receptor that contains the LBD of HR97g for 
transactivation assays. Three putative activators were identified in transactivation assays: 
cortisol, pyriproxyfen, and methyl farnesoate. Both methyl farnesoate and pyriproxyfen 
are juvenile hormone analogs that are male sex determinants in the otherwise female 
parthenogenic Daphnia. Concentration-response studies found that pyriproxyfen and 
methyl farnesoate have EC50’s of 3.4 and 2.2 µM, respectively.  In summary, HR97g is a 
candidate juvenoid receptor in the crustacean, Daphnia magna, because it is activated by 
juvenoids.  However, the lack of pharmacological inhibitors or targeted mutations limits 
our ability to conclude that HR97g is a JHA receptor involved in environmental sex 
determination.     
 
INTRODUCTION 
Nuclear receptors constitute a superfamily of transcription factors with a distinct five-
domain structure (Laudet & Gronemeyer, 2002). Of the five domains, the DNA binding 
domain (DBD, C domain) and the ligand binding domain (LBD; E domain) are the most 
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conserved domains. Ligand binding induces the interaction of the C domain with the 
response element of a gene, and typically results in an increase in transcriptional activity 
(Mangelsdorf et al., 1995).  
 
Since the cloning of the glucocorticoid receptor in 1985 (Hollenberg et al., 1985), new 
members have been constantly added to the nuclear receptor superfamily with the various 
sequencing and annotation projects providing valuable information on transcriptional 
regulation and evolution of the animal kingdom (Evans, 2005; Bridgham et al., 2010). 
The known nuclear receptors can be divided into seven subfamilies (Nuclear Receptors 
Nomenclature Committee, 1999) with diverse functions ranging from embryonic 
development, reproduction, nutrient allocation, detoxification, and in general the 
maintenance of homeostasis  (Benoit et al., 2006; Evans, 2005; Hernandez, Mota, & 
Baldwin, 2009).  
 
Daphnia magna, commonly known as the waterflea, is a crustacean in the Branchiopod 
class. It is a crucial component of the aquatic food web and is best known for its use as an 
aquatic toxicology test organism as it is easy to maintain and inexpensive to use. Eight 
percent of ECOTOX data for aquatic organisms are from Daphnia magna 
(http://daphnia.cgb.indiana.edu/people/news/47) making D. magna one of the most 
widely used aquatic toxicity test organisms.  Although the ecology of Daphnia magna is 
well understood, genomic studies on this organism have only recently been started. The 
Daphnia magna genome project is currently underway, and the Daphnia pulex genome 
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sequencing project was recently completed.  Daphnia are the first aquatic arthropod and 
the first crustacean fully sequenced (Colbourne et al., 2011), providing biologists with 
genomic information on the unique survival requirements of aquatic arthropods, and 
greater tools for studying arthropod evolution.   
 
Phylogenetic comparisons of the nuclear receptors from Daphnia pulex to other species 
demonstrate that Daphnia pulex contain three novel nuclear receptors placed in the newly 
formed NR1L group.  All three of these receptors are orphan receptors in that their 
ligands are not known.  We named them HR97a, HR97b, and HR97g because of their 
similarity to the NR1J group of nuclear receptors that includes HR96 found in Daphnia 
pulex and Drosophila melanogaster.  Phylogenetic data suggest that HR97g is the 
evolutionary precursor to the other two HR97 receptors found in tandem repeat 
(Thomson et al., 2009).   
 
While the ligands and function of the NR1L group is unknown, the similarity of these 
receptors to HR96 and the NR1I subfamily (HsVDR, HsCAR, HsPXR) suggests that this 
group might play a role in responding to environmental cues such as common xenobiotics 
or dietary endobiotics (Baskin-Bey et al., 2007; Finn et al., 2009; Hernandez et al., 2009; 
Horner et al., 2009; King-Jones et al., 2006; Sieber & Thummel, 2009; Sonoda et al., 
2005). The fact that this group exists in the crustacean Daphnia but not insects suggests 
the possibility of a unique adaptive pathway of detoxification in crustaceans, or an 
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endocrine process unique to crustaceans.  Conversely, insects may have lost the HR97 
group of nuclear receptors.   
 
Genomic data from the Daphnia genome projects are currently being used to determine 
how aquatic arthropods acclimate or adapt to environmental stressors including seasonal 
changes, food allocation, and aquatic toxicants (Miyakawa et al., 2010; Schwarzenberger, 
Courts, & von Elert, 2009; Schwerin et al., 2009; Scoville & Pfrender, 2010; Shaw et al., 
2007; Shaw et al., 2008; Spanier et al., 2010; Tollrian & Leese, 2010; Weber & Pirow, 
2009; Zeis et al., 2009).  This includes the role of stress in environmental sex 
determination and sexual reproduction, as parthenogenic Daphnia produce males for 
sexual reproduction when under specific stressful situations, and the molecular 
mechanisms behind male production and release is a key unsolved puzzle (B. D. Eads, 
Andrews, & Colbourne, 2008; B. D. Eads, Colbourne, Bohuski, & Andrews, 2007).  The 
Juvenoid methyl farnesoate (MF), and insecticidal juvenile  hormone analogs (JHAs) 
such as fenoxycarb and pyriproxyfen appear to control male production (Olmstead & 
Leblanc, 2002; Olmstead & LeBlanc, 2000; Tatarazako et al., 2003). A recent study has 
found a Doublesex gene (Dsx) in Daphnia that controls sexual dimorphism (Kato et al., 
2011). However, the link between MF and Dsx is missing. In other words, the receptor 
that responds to MF and induces expression of the Doublesex gene in Daphnia is not 
known.  
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Below we describe the partial characterization of the novel Daphnia nuclear receptor 
HR97g from Daphnia magna.  The study of the HR97g group will serve two purposes. 
First, it will broaden our current knowledge of nuclear receptor function and evolution. 
Second, it may reveal some new molecular basis for Daphnia physiology, potentially 
providing novel genetic support to some long-established toxicity tests.  In this study 
magnaHR97g was cloned, sequenced and compared genomically and phylogenetically 
with similar receptors in the NR1 subfamily. A GAL4-97gDEF chimeric plasmid was 
constructed with the magnaHR97g D, E and F domains (Thomson et al., 2009). 
Transactivation assays were conducted to measure HR97g activity under different 
conditions and in the presence of different chemicals, including the juvenile hormone 
analogs (JHA), methyl farnesoate and pyriproxyfen, involved in male production.  This is 
the first study to examine the putative functions of HR97g.    
 
MATERIALS and METHODS 
D. magna:  
Our colony of D. magna has been cultured at Clemson University for over 15 years and 
was provided by Dr. Steve Klaine (Clemson University). Daphnids were maintained at 15 
individuals/L in 22oC deionized water reconstituted with MgSO4•7H2O 123 mg/L, 
CaSO4 60 mg/L, KCl 4 mg/L and NaHCO3 96 mg/L under a 16:8 light:dark photoperiod 
in an environmental chamber.  Daphnids were fed twice daily with 6 X 106 cells of 
Celenastrum capricornutum and 10µL (~ 0.1 mg dry weight) Tetrafin fish food 
suspension (Tetra Holding Inc, VA) per adult daphnid. 
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Nucleotide extraction: 
RNA was extracted from fresh female Daphnia magna of a variety of ages (2-14 days 
old). RNA was extracted with PureZol (BioRad, Hercules, CA) according to the 
manufacturer’s directions followed by digestion of residual genomic DNA with DNAse 
(Promega, Madison, WI). Complementary DNA was synthesized from 2µg of RNA with 
Moloney Murine Leukemia Virus-Reverse Transcriptase (MMLV-RT), a dNTP mixture, 
and random hexamers (Promega).   
     
Cloning Daphnia magna HR97g (magnaHR97g):   
The Daphnia HR97g transcript was cloned by a combination of using primer sets 
designed from highly conserved regions of nuclear receptors and rapid amplification of 
cDNA ends (RACE).  Primer sets (F = forward; R = reverse) F5/R4, F1/R1, and F97g-
GL/R-97g-GL (kindly provided by Gerald LeBlanc, North Carolina State University) 
were designed based on the D. pulex HR97g sequence (Thomson et al., 2009) 
(http://genome.jgi-psf.org/cgi-
bin/browserLoad?db=Dappu1&position=scaffold_40:123499-125619).  F5: 5’-
GAAGATGTCCAGCGTCTTCT-3’; R4: 5’-TCAATTTGCGCCAGTTC-3’; F1:5’-
ATGGATGACAGCAACAGTTCT-3’; R1:5’-CGAAGCCATCCTTTCTCCAT-3’; 
F97g-GL: 5’-ACATGGCCAAACATGTGTCA-3’; R97g-GL: 5’-
TGTCTTCAAAGCTTGGTTCG-3’. PCR products were ligated into pCR 2.1 by TA 
cloning (Invitrogen, Carlsbad, CA).  Fm2/Rm2 primer pair (Fm2: 5’-
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CCAATTGGTGCAACACTCCTAG-3’; Rm2: 5’-GCTCGATCGGGCGTAAACAT-3’) 
was designed after sequencing the PCR products from the previous reactions and used to 
determine the unknown areas within the middle of the gene.  The 3’ end of magnaHR97g 
was cloned following 3’-RACE (Invitrogen, Carlsbad, CA) with the following primers: 
F-GSP1: 5’-CCTGGAAGATGTCCAGCGCCTTCT-3’; nested primer F-GSP2: 5’-
GCCCGATCGAGCAGATCTTGTTGCTCGT-3’. DNA sequencing was performed by 
MacrogenUSA (Rockville, MD).   
   
Genomic structure:   
Genomic sequencing of D. magna clone Xlnb3 from Finland (Fin-magna) is currently 
underway.  We were able to use the partial genomic data available to compare the 
magnaHR97g genes in different strains.  Our Clemson magnaHR97g sequence was 
blasted to the D. magna genome.  The genomic structure of magnaHR97g was 
determined by the position, length, and phase of each intron (D. magna genome).  Protein 
sequence identities of each nuclear receptor domain was compared between 
magnaHR97g, Fin-magnaHR97g, D. pulex HR97g (DappuHR97g), D. pulex HR97a 
(DappuHR97a), D. pulex HR97b (DappuHR97b), D. pulex HR96 (DappuHR96), 
Drosophila melanogaster HR96 (DHR96), C. elegans DAF12, and Homo sapiens 
constitutive androstane receptor (CAR) using ClustalW 
(http://www.ebi.ac.uk/Tools/clustalw2/).  Appendix A contains the accession numbers of 
each receptor used in the analysis.  In addition, intron-exon junctions and intronic size 
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were compared between the D.magna strain Fin-magnaHR97g, and D. pulex HR97g 
(DappuHR97g).   
 
Phylogenetics:   
Phylogenetic analyses of HR97g and the related NR1I group of receptors was performed 
using methods described previously (Hannas et al., 2010; Thomson et al., 2009) with 
some modification.  HR97g from D. magna was compared to those of other species 
available in GenBank, including Drosophila melanogaster, Homo sapiens, Danio rerio, 
C. elegans, and Daphnia pulex.  NCBI accession numbers for the receptors used are 
available in Appendix A.  The DNA binding domain (DBD) and the ligand binding 
domain (LBD) of each receptor were identified using the conserved domain database 
(CDD) (Marchler-Bauer et al., 2005). Zf-C4 (pfam00105) was used to identify the DBD 
and Hormone Recep (pfam00104) was used to identify the LBD.  Analysis was 
performed with the DBD alone, LBD alone, and DBD and LBD joined.  ClustalX default 
parameters were used to align the domains (Thompson, Gibson, Plewniak, Jeanmougin, 
& Higgins, 1997). Phylogenetic analysis using the combined LBDs and DBDs of the 
nuclear receptors is provided in the manuscript, while the phylogenetic analysis of the 
DBDs only, and the LBDs only are presented as Appendices B and C.   
 
Trees were constructed using Bayesian Inference with MrBayes software version 3.1.2 
(Ronquist & Huelsenbeck, 2003) on the Computational Biology Service Unit of Cornell 
University (http://cbsuapps.tc.cornell.edu/mrbayes.aspx).  Phylogenetic trees were 
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constructed using the “mixed-model” approach in which the Markov chain Monte Carlo 
sampler explores nine different fixed-rate amino acid substitution models implemented in 
MrBayes. We used 4 chains with runs of 5 million generations, chains sampled every 100 
generations, a burnin of 10,000 trees with the WAG model (Whelan & Goldman, 2001). 
The Daphnia magna ecdysone receptor was used as an outgroup.   
 
Maximum Parsimony and distance parameters were used to provide additional support 
for the phylogenetic relationships observed. Distance parameters were measured using 
PAUP 4.0b10 with default characteristics (mean character difference and among site rate 
variation), and full heuristic searches. Branch support was measured by bootstrap 
analysis with 1000 replicates. Parsimony was constructed using PAUP version 4.0b10 
with heuristic searches, tree-bisection-reconnection, topological constraints not enforced, 
and multiple tree option in effect with an initial maximum tree setting at 100,000.  
Branch support was measured by bootstrapping with 10,000 replicates. Trees were 
visualized with FigTree (http://tree.bio.ed.ac.uk/software).  
 
Chimeric expression plasmids:   
The GAL4-97gDEF chimeric plasmid was constructed according to the Clontech In-
Fusion Dry-Down PCR Cloning Kit protocol (Clontech Laboratories, Mountain View, 
CA).  The D, E and F domains of magnaHR97g were amplified using primer pair F-
clontech-97g-BamHI (5’-GAA TTC CCG GGG ATC GAA GAA AAT GTG AAA ATG 
AGA GAG GCC AAG-3’) and R-clontech-97g-XbaI (5’-CTG CGG CCG CTC 
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TAGATTA AAC TGG GTT ATC TGT TTC CAT TTG TTG ACT-3’). The PCR 
product was inserted into the pBIND vector (Promega CheckMate Mammalian Two-
hybrid system) in frame after the GAL4 DNA binding domain. This plasmid expresses a 
chimeric protein consisting of the GAL4 DNA binding domain and HR97g hinge (D), 
ligand binding (E), and F domains. 
 
Transactivation Assays: 
HEPG2 human hepatoma cells (ATCC, Rockville MD) were cultured in phenol red free 
Dulbecco’s Modified Eagle’s Medium (DMEM) (Mediatech, Manassas, VA) 
supplemented with 10% fetal bovine serum (HyClone, Logan, UT), 1% L-glutamine 
(Invitrogen, Carlsbad, CA) and 1% Penicillin/Streptomycin (Invitrogen, Carlsbad, CA) at 
37 °C under 5% CO2. 
 
HepG2 cells were plated in 12-well plates at 200,000 cells per well. Typically, cells were 
transfected with 0.02 µg of the GAL4-97gDEF chimeric plasmid and 0.1 µg of the 
reporter plasmid pG5luc that contains five GAL4 binding sites upstream of the firefly 
luciferase gene (Promega CheckMate Mammalian Two-hybrid system) using Effectene 
Transfection Reagent according to the manufacturer’s recommendations (Qiagen, 
Valencia, CA). On the third day cells were either left untreated or treated with the 
chemicals of interest dissolved in 0.1% DMSO.  Control wells also received 0.1% 
DMSO. Luciferase activity was measured 24 hours later with the Steady-Glo Luciferase 
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Assay System (Promega, Madison, WI) in a Turner Biosystems 20/20n luminometer 
(Promega, Madison, WI).  
 
Several hormones, fatty acids, and xenobiotics were used to test whether they activated 
HR97g.  These include 4-nonylphenol (CAS 84852-15-3), bisphenol A (80-05-7), 
chlorpyrifos (2921-88-2), cortisol (50-23-7),  dihyroandrosterone (1852-53-5), ethyinyl 
estradiol (57-63-6), β-estradiol (50-28-2), endosulfan (115-29-7), parathion (56-38-2), 
methyl farnesoate (10485-70-8), palmitic acid (57-10-3), and stearic acid (57-11-4).  
 
Data are presented as the mean of triplicate assays + standard error.  Statistical 
significance was determined by ANOVA followed by Dunnett’s test as the post hoc test 
using the GraphPad Prizm 4.0 statistical and graphing package (La Jolla, CA). For the 
dose-response studies, activities were normalized as a percent of the maximal activation 
and concentrations were log transformed. EC50 values and Hillslopes of each chemical 
were derived from the sigmoid dose-response curves generated by GrapPad Prizm 4.0 
(Baldwin & Roling, 2009).  
 
RESULTS 
Genomic Structure: 
The position, length, and phase of each intron and exon of Fin-magnaHR97g was 
determined and compared with DappuHR97g (Figure 2.1).  The intron phases are 
identical between DappuHR97g and magnaHR97g, and the exon sizes are nearly the 
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same with the exception of the fourth exon that contains the highly variable F-domain.  In 
addition, the protein sequence of each domain of magnaHR97g was aligned with the 
corresponding domain of several other NR1 subfamily members including Fin-
magnaHR97g, DappuHR97g, DappuHR97a, DappuHR97b, DappuHR96, CeDAF12, 
DmDHR96, and HsCAR and percent identity was determined (Table 2.1).  Our Clemson 
magnaHR97g sequence agrees well with only minor variances from the HR97g from the 
Finnish strain of D. magna (Fin-magnaHR97g) whose genome is currently being 
sequenced.  The five domains of HR97g are also similar between D. magna and D. pulex, 
especially in the DNA and ligand binding domains (Appendix D contains a ClustalX 
document comparing D. pulex and D. magna HR97g).  However, HR97g varies 
considerably from the other nuclear receptors including the highly related HR97a/b 
receptors as well as the HR96 receptor.  This suggests that each of the HR97 receptors 
evolved to accommodate different ligands and probably activate different enhancer 
elements on DNA.      
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Figure 2.1 Comparison of the gene structure of HR97g from D. magna and D. pulex. 
The blocks represent exons, the numbers indicate the size of the introns and exons, and 
the numbers in parentheses represent the intron phases.  The inron phases were identical 
between the two species as was the placements of the DBD and LBD within the first and 
third exons, respectively.    
 
 
Table 2.1 Domain comparison between magnaHR97g and other NR1 subfamily 
members. Data shown as identity scores to magnaHR97g derived from ClustalW. 
 
NR      A/B C D E F 
magnaHR97g 100 100 100 100 100 
Fin-magnaHR97g 100 97 99 99 100 
DappuHR97g 83 84 70 90 76 
DappuHR97a 25 63 32 40 10 
DappuHR97b 12 63 33 38 10 
DappuHR96 8 51 23 28 33 
CeDAF12 12 48 14 11 0 
DmDHR96 25 5 16 22 50 
HsCAR 25 44 5 17 50  
 
Phylogenetics:   
The HR97 group (putative NR1L group) of nuclear receptors was first discovered as part 
of the Daphnia pulex genome project (Thomson et al., 2009). Daphnia species are 
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currently the only species known to contain HR97 members; however, Daphnia pulex are 
the only crustacean species fully sequenced.  The NR1L group is related to the NR1J 
group that contains HR96 (Thomson et al., 2009), which in turn is related to the NR1I 
group containing CAR, PXR, and VDR (Lin, Kozaki, & Scott, 2010). Therefore, the 
NR1I, NR1J, and NR1L receptors were compared phylogenetically. In addition, the 
knirps that are members of the NR0A group but phylogenetically related to HR96 and 
HR97 (Thomson et al., 2009) were also examined.   
 
The DBD/LBD combined phylogenetic tree separates into four distinct clades; one 
containing the HR97 group (NR1L), one containing the HR96 group (NR1J), one 
containing CAR/PXR/VDR (NR1I), and one containing the knirps involved in fruitfly 
development (NR0A) (Figure 2.2). This data verifies that the HR97s are deserving of 
their own distinct nuclear receptor group. In addition, the phylogenetic tree confirms that 
magnaHR97g is highly related to DappuHR97g, substantiating that HR97g is found in 
another cladoceran species. Phylogenetic analysis also confirms that the HR97 group is 
closely related to the NR1I and NR1J groups with a closer relationship to the NR1J 
(HR96) group than the NR1I (VDR/PXR/CAR) group (Figure 2.2).  
 
Interestingly, distance methods show some disagreement as they estimate that 
NR1L(HR97)/NR1J(HR96) are more closely related to the knirps than they are to the 
NR1I group (CAR/PXR/VDR) with a bootstrap value of 61.  
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Because the knirps lack a LBD, we also did the phylogenetic analysis using only the 
DBDs or LBDs (Appendices B and C).  The DBD only phylogenetic tree suggested a 
different relationship between the receptors than the LBD containing trees.  DBD-only 
trees show four distinct groups divided into two parent clades; one clade contains the 
NR1I and NR1J groups, and the other clade contains the NR1L (HR97) and knirps 
(NR0A) using Bayesian analysis.  This indicates that the DBDs of the HR97 receptors are 
more closely related to the knirps than the other receptors, and suggests a potential role of 
the HR97 receptors in transcriptional activation of genes involved in development.  
However, neither NJ nor Maximum Parsimony agrees with this conclusion and the 
posterior probabilities are not significant.  
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 Figure 2.2 Phylogenetic analysis of HR97g.  The nuclear receptors within the 0A 
(knirps), NR1I, 1J, and 1L groups from several different species including Homo sapiens 
(Hs), D. magna (magna), D. pulex (Dappu), Drosophila melanogaster (Dm), C. elegans 
(Ce), Ciona intestinalis (Ci) were subjected to phylogenetic analysis.  Bayesian Inference, 
Neighbor-Joining, and Maximum Parsimony were used to determine the relationship of 
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HR97g to the NR1J and NR1I groups.  The Bayesian tree is shown with posterior 
probabilities from the Bayesian tree, and bootstrap support values (frequency of 
occurrence) from the Neighbor-Joining and Maximum Parsimony trees provided in order 
from left to right, respectively as confirmatory analysis of the Bayesian analysis.  
Posterior probability values are separated by forward slashes at each corresponding node; 
an X indicates an area of disagreement from the Bayesian tree. D. magna EcR was 
chosen as an outgroup.  Accession numbers of the analyzed nuclear receptors are 
provided in Appendix A. 
 
 
HR97g Transactivation 
Cells were transfected with GAL4-97gDEF chimeric expression plasmid and the pG5luc 
to determine if HR97g has constitutive activity in HepG2 cells. Control cells were 
transfected with 0.1 µg of the pG5luc reporter plasmid only. The luciferase assay shows 
that HR97g represses transcription in the absence of an activator (Figure 2.3A). 
Therefore, we transfected cells with increasing concentrations of the GAL4-97gDEF 
chimeric plasmid to test whether there is a dose-dependent pattern. To ensure that each 
well received equal amounts of plasmid, the empty pBIND plasmid was co-transfected 
into each well so that the plasmid concentration was equal (0.08 µg) in all of the wells.  
HR97g exerted a weak, but discernable dose-dependent repression on transcriptional 
activity in the absence of an activator (Figure 2.3B), suggesting that HR97g is a 
transcriptional repressor in the absence of activators. Other nuclear receptors, such as 
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PXR, have also been found to repress gene expression in the absence of ligands because 
of their recruitment of co-repressors (Ourlin et al., 2003; Takeshita, Taguchi, Koibuchi, 
& Ozawa, 2002). 
 
Transactivation assays were performed in the presence of several different chemicals to 
test whether HR97g acts as a promiscuous xenobiotic/endobiotic sensor similar to the 
some of the NR1I and NR1J receptors (Baldwin & Roling, 2009; Hernandez et al., 2009; 
Kliewer et al., 1998; Lin et al., 2010).  Cells were treated with 4-nonylphenol, 
chlorpyrifos, endosulfan, parathion, bisphenol A, stearic acid, palmitic acid, β-estradiol, 
1,3,5 (10)-estratrien-17α ethynyl-3,17β-diol (ethynyl estradiol), cortisol, and 
pyriproxyfen at 10 µM. Of the chemicals tested, only the stress hormone, cortisol and the 
JHA, pyriproxyfen significantly activated transcription (Figure 2.4).  Pyriproxyfen 
increased luciferase activity 54% and cortisol increased activity 32%.   
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Figure 2.3 HR97g acts as a transcriptional repressor in the absence of activators. A) 
HepG2 ells were transfected with pBIND-GAL4-97gDEF chimeric plasmid and the 
reporter plasmid, pG5luc. Control cells were transfected with pG5luc only, and 
transactivation activity was measured as described in the Materials and Methods. B) Cells 
were transfected with 0, 0.01, 0.02, 0.04 and 0.08 µg pBIND-GAL4-97gDEF chimeric 
plasmid supplemented with empty pBIND-GAL4 vector to ensure all wells contained 
0.08µg of vector. The assay was repeated two times.  An asterisk or two asterisks 
indicates statistical significance at p < 0.05 or p < 0.01 as determine by Student’s t-test 
(A) or ANOVA followed by Dunnett’s multiple comparison test (B) with GraphPad 
Prizm 4.0 (La Jolla, CA) (n = 3).  
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Figure 2.4 Chemical activation of HR97g.  Transactivation assays were performed with 
several chemicals to determine if they activate HR97g.  Only cortisol and pyriproxyfen 
significantly increased activation as determined by ANOVA followed by Dunnett’s 
multiple comparison test as the post-hoc test.  An asterisk indicates p < 0.05 and two 
asterisks indicate p < 0.01 (n = 3).   
 
Pyriproxyfen and methyl farnesoate dose response assays 
To determine whether HR97g contributes to the regulation of  male sex determination, 
dose-response transactivation assays were performed with both the juvenile hormone 
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analog pyriproxyfen, and the endogenous juvenoid hormone methyl farnesoate (MF). 
Pyriproxyfen increased transcriptional activation in a dose-dependent fashion with peak 
activation at 10 µM and a significant decrease at 30 µM, presumably because of cell 
toxicity (Figure 2.5A). Dose-response curves (Figure 2.5B) determined that the EC50 of 
pyriproxyfen is 3.36 µM (Table 2.2).  MF also activates HR97g.  Luciferase activity was 
increased in the presence of MF in a dose-dependent manner with 30 µM MF exerting 
maximal transcriptional effects (Figure 2.5C).  The EC50 of MF is 2.22 µM (Figure 
2.5D) demonstrating that both JHAs activate HR97g transcriptional activity in the low 
micromolar range (Table 2.2).  
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Figure 2.5 Pyriproxyfen and methyl farnesoate increase luciferase activity in 
transactivation assays in a dose-dependent manner. Cells transfected with the GAL4-
97gDEF and the pG5luc reporter were treated with pyriproxyfen (A) at concentrations of 
3, 10, and 30 µM and luciferase activity measured as described in the Materials and 
Methods.  B) Sigmoidal dose-response for pyriproxyfen at concentrations ranging from 
0.01 µM to 10 µM. C) Cells transfected with GAL4-97gDEF and pG5luc were treated 
with methyl farnesoate at concentrations of 3, 10, and 30 µM and luciferase activity 
measured. D) Sigmoidal dose-response curve of methyl farnesoate at concentrations 
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ranging from 0.1 µM to 30 µM.  Dose-reponse curves and EC50s were determined with 
GrapPad Prizm 4.0 (n = 3).  
  
Table 2.2 EC50 and 95% Confidence Interval (CI) of the HR97g activators, 
pyriproxyfen and methyl farnesoate.    
JHAs EC50 
(µM) 
95% CI 
(µM) 
Pyriproxyfen 3.36 2.00-5.64 
MF 2.22 1.23-4.00  
 
DISCUSSION: 
Few of the chemicals tested in transactivation assays increased HR97g activity.  All three 
of the chemicals that induced luciferase activity are stress hormones or analogs of stress 
hormones.  Two of the three activators of HR97g are the pesticide and juvenile hormone 
analog, pyriproxyfen, and the endogenous crustacean juvenile hormone, methyl 
farnesoate.  The discovery that magnaHR97g is activated by JHAs is interesting because 
most JHAs induce the production of males with high efficacy (Olmstead & Leblanc, 
2002; Tatarazako et al., 2003), and the production of males is the first step in the switch 
from parthenogenic reproduction to sexual reproduction.  
 
Because HR97g and the other HR97 receptors (NR1L group) are a novel group of nuclear 
receptors, we investigated their relationship to other nuclear receptor groups.  
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Phylogenetically, the HR97 receptors are related to the NR1J group that contains HR96 
and DAF12.  Both of these groups are related to the NR1I group of nuclear receptors that 
contain CAR, PXR, and VDR.  The function of magnaHR96 is unknown, but Drosophila 
HR96 is activated by phenobarbital and induces a number of detoxification enzymes 
similar to CAR and PXR (King-Jones et al., 2006). Therefore, we hypothesized that 
HR97g may be a promiscuous toxicant receptor activated by a plethora of environmental 
chemicals; however our data does not support this hypothesis as only cortisol and JHAs 
activated HR97g.  Furthermore, analysis of the percent identities of the different domains 
from CAR, DappuHR96, and Drosophila HR96 (Table 2.1) suggests that the HR97 
receptors probably bind different chemicals and activate the transcription of different 
genes.    
 
Daphnia switch from parthenogenic cloning of females to sexual reproduction because of 
several different environmental signals such as short day length, food shortage, and high 
population density (Tatarazako & Oda, 2007). The key step in the response of Daphnia to 
these stressful conditions is producing males (Hebert, 1978). Males are required for  
mating with adult females to produce resting eggs covered with an ephippium that is 
capable of enduring adverse conditions for long periods of time (Hebert, 1978). Juvenile 
hormones such as MF induce male production (Olmstead & Leblanc, 2002). However the 
MF receptor is not known. Both MF (sesquiterpenoid) and all-trans-retinoic acid 
(diterpenoid) are terpenoid signaling molecules that mediate development processes.  
Therefore, speculation has revolved around RXR as it is a retinoid binding hormone in 
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mammals and its insect homolog, USP/RXR, is bound and activated by JH at low 
micromolar concentrations (Jones & Sharp, 1997). However, recent research 
demonstrated that crustacean RXR is not activated by MF, and activation of RXR by 
other ligands such as tributyltin does not increase male production (Wang & LeBlanc, 
2009), indicating that RXR is not a crucial receptor in male production.  
 
Here our data show that HR97g may be a candidate MF receptor.  However, receptor 
activation was not potent. This could be caused by the assay, high constitutive activity, or 
the lack of key Daphnia cofactors.  The development of a Daphnia cell line would be 
helpful.  Furthermore, the EC50’s we observe here are usually considered 
pharmacological-type and not the high affinity EC50’s observed for the steroid receptors; 
methyl farnesoate has an EC50 of 2.2µM and pyriproxyfen has an EC50 of 3.4µM for 
HR97g.  Nevertheless, these EC50’s are within the physiological concentration range of 
typical adopted orphan receptors.  For example, the EC50 of 9-cis-retinoic acid for RXR 
is 0.5 µM (Schwimmer et al., 2004), while the EC50 of the putative endogenous RXR 
ligand docosahexaenoic acid is > 50 µM (Calderon & Kim, 2007).  Therefore, we 
consider MF a putative HR97g ligand. 
 
In addition, in vivo activity and in vitro transactivation are at comparable doses. 
Pyriproxyfen activates 100% male production in a daphnid’s third brood at about 0.3 
µg/L (934 pM) (Tatarazako et al., 2003).  Pyriproxyfen’s bioconcentration factor (BCF) 
in fish is 1397-1495 (Report, 2009).  Using this calculated BCF from fish estimates a 
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body burden of pyriproxyfen after 934 pM exposure in Daphnia of approximately 1.4 
µM or close to the EC50 of pyriproxyfen for HR97g in transactivation assays.  MF 
causes 100% male production at about 100 µg/L (400 nM) (Olmstead & Leblanc, 2002).  
MF’s BCF has not been tested to our knowledge, but if it has a bioconcentration factor of 
100, which is reasonable, then it would reach concentrations of approximately 40 µM in 
the Daphnia, well above the EC50 of MF for HR97g. Therefore, the EC50s of 
pyriproxyfen and methyl farnesoate are within the range necessary to cause male 
production in vivo. 
 
Currently, there is not enough evidence to conclude that HR97g is the MF receptor 
involved in male production.  HR97g may work in combination with another receptor to 
enhance MF binding. For example, HR97g may interact with another receptor in a 
manner similar to how several receptors interact with RXR (Amoutzias et al., 2007). 
Activation may also be enhanced by co-transfection of the proper co-activators (Fleming 
et al., 2004; Kamei et al., 2003). It is also possible that HR97g is only one of several JH 
receptors in Daphnia, in which case it would not necessarily be the specific receptor 
involved in male production.  
 
It is not unusual for an organism to have multiple receptors responding to one chemical 
signal. For example, there are three groups of receptors activated by retinoic acids in 
humans with different developmental and tissue-expression.  These include receptors 
from the NR1B (RARa, RARb, RARg), NR2B (RXRa, RXRb, RXRg) (Chambon, 1996) 
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and NR2F (COUP-TFI, COUP-TFII, EAR2) groups, although in the NR2F group only 
COUP-TFII has been shown to bind retinoids (Kruse et al., 2008).  Therefore, there may 
be several MF receptors in crustacea; each one with a different function or expression 
pattern so that juvenile development and environmental sex determination may be 
controlled by one hormone reducing the need for new hormone synthesis pathways.  
Juvenile hormone also functions in juvenile development and reproductive maturation 
(Riddiford, 2008). Therefore, we must consider that HR97g may be influencing these 
functions in addition to or instead of environmental sex determination.   
 
Determining the exact function of HR97g in vivo may be difficult as knockout 
technologies are not currently available in Daphnia.  Preliminary reports suggest that 
RNAi may be available soon; however this technology has only been used successfully 
for a short period of time in developing embryos and not in reproductive adults (Kato et 
al., 2011).  Furthermore, the proper vectors for long-term repression of expression have 
not been explored in Daphnia species.  Thus, the physiological function of HR97g may 
need to be estimated based on pharmacological studies, different Daphnia ecotypes, and 
circumstantial evidence until these techniques are available.  
 
The purpose of our research was to characterize HR97g, a novel nuclear receptor found 
in Daphnia species related to the NR1I and NR1J groups.  Unlike some of the receptors 
found in the NR1I (CAR/PXR) or NR1J (HR96/CeNHR8/CeNHR48) groups, HR97g is 
not promiscuous.  Instead it is activated by the juvenile hormone analogs MF (the 
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endogenous hormone) and pyriproxyfen (pesticide).  The data provide intriguing 
evidence that HR97g may be a MF receptor.   
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CHAPTER THREE 
CHARACTERIZATION OF NUCLEAR RECEPTORS HR97A AND HR97B IN 
DAPHNIA MAGNA 
 
ABSTRACT  
Annotation of the Daphnia pulex nuclear receptors revealed a novel group of receptors 
designated NR1L, with its three members named HR97a/b/g. We cloned and sequenced 
the two duplicated forms found in tandem repeat, HR97a and HR97b, from Daphnia 
magna. We analyzed their genomic structure, and conducted phylogenetic studies that 
demonstrate their similarity to each other, but indicate significant differences from their 
ancestor HR97g. Gal4-chimeric plasmids were constructed that contain the LBD of 
HR97a/b for transactivation assays. Interestingly, HR97a represses transcription in the 
absence of a activator similar to many other nuclear receptors; however, HR97b has 
constitutive activity similar to the constitutive androstane receptor (CAR), a related NR1I 
member. Phylogenetic studies show that the HR97s do form a distinct group, and the 
newly-discovered Ixodes IsHR97 is also a member of this group. Although NR1L is 
phylogenetically related to NR1I and NR1J, the HR97s share little amino acid sequence 
identity with the NR1I and NR1J members, many of which are xenosensors (Fin-
magnaHR96, DmDHR96, CeDAF12 or HsCAR). Further, transactivation assays found 
pyriproxyfen, the juvenile hormone analog that induces the production of males in the 
otherwise female parthenogenic Daphnia, activates HR97a and b. 
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INTRODUCTION 
Nuclear receptors are a superfamily of transcription factors involved in diverse 
physiological functions ranging from reproduction, development, homeostasis and 
detoxification through direct or indirect transcriptional regulation (Benoit et al., 2006; 
Evans, 2005; Hernandez, Mota, & Baldwin, 2009). The regulatory function of nuclear 
receptors is made possible by their unique five-domain structure (Laudet & Gronemeyer, 
2002). From the N-terminal to the C-terminal there is the A/B domain that functions in 
ligand-independent transcriptional activation (AF-1), the C domain that binds to the 
response element of a gene (DNA binding domain; DBD), D domain that is the hinge 
domain between the C and E domain, E domain that is the ligand binding domain (LBD), 
and the highly diverse F domain. Of the five domains, C is highly conserved and E is 
moderately conserved. The C domain is the most conserved domain because it binds to 
DNA at well-conserved response elements. Binding of a small lipophilic compound 
(ligand) to the E-domain, (Kozlova, Lam, & Thummel, 2009), usually leads to a series of 
conformational changes in the receptor, typically resulting in translocation to the nucleus, 
DNA binding, and ultimately transcriptional activation (Mangelsdorf et al., 1995).  
 
Studies on nuclear receptor function and phylogenetics are crucial to understanding 
metazoan evolution as nuclear receptors have gone through numerous duplication events 
during evolution. In the recent sequencing of the Daphnia pulex genome, which is also 
the first full genome sequencing project on crustaceans (http://wFleaBase.org), 25 nuclear 
receptor genes with a conserved DBD have been identified (Thomson et al., 2009). It has 
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been estimated that there are 48 nuclear receptors in Homo sapiens, 21 in Drosophila 
melanogaster, and over 270 in Caenorhabditis elegans (Adams et al., 2000; Robinson-
Rechavi, Carpentier, Duffraisse, & Laudet, 2001; Sluder & Maina, 2001). This diversity 
is interesting because it is likely to reveal the time and roles of gene duplications in 
evolution and facilitate phylogenetic reconstruction (Escriva Garcia, Laudet, & 
Robinson-Rechavi, 2003). For example, a recent study, using genomic, biochemical, 
functional, structural, and phylogenetic analyses, has shown that modern nuclear 
receptors evolved through subtle tinkering of a ligand-dependent ancestral receptor 
(Bridgham et al., 2010). 
 
Comparisons of the nuclear receptors from Daphnia pulex to other species indicate that 
Daphnia have a novel group of nuclear receptors. This group is designated the NR1L 
group.  Its three members are named HR97a, HR97b, and HR97g because of their 
similarity to HR96 (NR1J) found in both in Daphnia pulex and Drosophila melanogaster 
(Thomson et al., 2009). In Chapter two we described our characterization of HR97g, the 
evolutionary precursor to the HR97a and HR97b receptors. Here we will focus on HR97a 
and HR97b, which are found in tandem repeat in the D. pulex genome (Thomson et al., 
2009). We used D. magna in this study because it is widely used in aquatic toxicicity 
tests as a surrogate organism for other pelagic aquatic invertebrates, and the D. magna 
genome project is currently underway. We hope this study will provide mechanistic 
support to some long-established toxicity tests as well as broaden our current 
understanding of nuclear receptor functions and phylogenetics.  
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In this study, D. magna HR97a and HR97b (magnaHR97a and magnaHR97b) were 
cloned using 5’- and 3’-RACE, sequenced, analyzed and compared phylogenetically with 
other receptors in different species. GAL4-97a/b DEF chimeric plasmids were 
constructed with the magnaHR97a/b D, E and F domains (Thomson et al., 2009), and 
transactivation assays were performed to determine HR97a/b activity under different 
conditions and in the presence of different chemicals, including pyriproxyfen, the 
juvenile hormone analog that has been discovered to activate magnaHR97g (Chapter 
Two). 
 
MATERIALS and METHODS 
Daphnia culture: Our colony of D. magna was kindly provided by Dr. Steve Klaine 
(Clemson University). The moderately hard water used in Daphnia culture was deionized 
water reconstituted with MgSO4•7H2O 123 mg/L, CaSO4 60 mg/L, KCl 4 mg/L and 
NaHCO3 96 mg/L. The population was maintained at 22oC under a 16:8 light:dark 
photoperiod in an environmental chamber with 15 adult daphnids/L.  Daphnids were fed 
twice daily with 6 X 106 Selenastrum capricornutum algal cells per adult daphnid  and 
0.15 mL Tetrafin fish food suspension per liter of media (Tetra Holding Inc, VA) 
(Chapter Two). 
 
RNA isolation and cDNA synthesis: RNA was extracted from fresh female Daphnia 
magna with Tri-Zol (BioRad, Hercules, CA) according to the manufacturer’s directions.  
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DNA digestion using DNAse (Promega, Madison, WI) was subsequently performed, and 
cDNA synthesized by reverse transcription of 2µg of RNA with 200 units Moloney 
Murine Leukemia Virus-Reverse Transcriptase (MMLV-RT), a 10mM dNTP mixture, 
and 0.05 mg random hexamers (Promega Corporation, Madison, WI) . 
 
Cloning HR97a from D. magna: A small piece of magna HR97a gene was isolated 
using a pair of primers provided by Dr. Gerald LeBlanc at North Carolina State 
University: F-97a-GL: 5’-CCAACTCGAGTGGAGGAGAG-3’; R-97a-LeBlanc: 5’-
GCCACCTTTGAGCAGGATAC-3’. The PCR product was ligated into pCR 2.1 by TA 
cloning (Invitrogen, Carlsbad, CA). DNA sequencing was performed by MacrogenUSA 
(Rockville, MD). The Invitrogen 3’ RACE kit (Invitrogen, Carlsbad, CA) was used to 
amplify the 3’ half of the gene. The forward primer used in the first 3’ RACE PCR is F-
97a-GL. F-GSP-97a (5'- TAC GCT CGC TTG ATG GCC GAC -3') was used in the 
nested PCR. After that, PCR was performed using primer pair 97a-F2/R-97a-GL. 97a-F2 
(5’-CAAGAGTTACCATTTCGGCG -3’) was designed based on D. pulex’s sequence.  
The cloning of 97a was completed with the Invitrogen 5’ RACE kit (Invitrogen, 
Carlsbad, CA). The steps of 5’ RACE include first strand cDNA synthesis, TdT tailing of 
cDNA and PCR of dC-tailed cDNA. Two reverse primers were designed based on the 
known magnaHR97a sequence determined from the work described above. Primer 
sequence information: R-GSP6-97a: 5’- CACACTGGCCACGGTGACAGCAC – 3’; R-
GSP7-97a: 5’ – CGGAACGACGAAAGAAAGCCTTGC – 3’. The former was used in 
the first 5’ RACE PCR and the latter was used in the nested PCR. 
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Cloning HR97b from D. magna: A small piece of D. magna HR97b gene was isolated 
using a pair of primers provided by Dr. Gerald LeBlanc from the D. pulex genome 
project: F-97b-GL (5’-GAG CTG CCT TCT GAA AGG TG-3’) and R-97b-GL  (5’-GCG 
TGA ACA GAA CGA TCA AG-3’). The 3’-end of the HR97b gene was cloned via 3’-
RACE (Invitrogen, Carlsbad, CA). Forward primer used in the first 3’-RACE PCR is F-
97b-GL. F-GSP-97b (5'- GGG AGT CGA CGA ACC GAC CAT CAT -3') was used in 
the nested PCR.  Two rounds of 5’-RACE (Invitrogen, Carlsbad, CA) was performed to 
isolate and determine the 5’-sequence of HR97b with gene specific and nested primers 
(5’ – GGACATGTTGGCGTTTGGCCAGCG – 3’; nested: 5’ – 
ACGGGTCGTAGACTAGCGCTCCTC – 3’) (5’ – 
GCTCGAAAAGTCGGCCATCAGCCG – 3’; nested: 5’ – 
GGCGAAACGACGAATCAGAGTCCC -3’).  
 
Genomic structure:  We blasted our Clemson magnaHR97a and HR97b sequences to 
the genomic sequences from D. magna clone Xlnb3 (Fin-magnaHR97a/b).  Xlnb3 is the 
strain of D. magna isolated from a pond in Finland of which the genomic sequencing is 
currently underway.  We were able to find the corresponding HR97a and HR97b 
sequences in the scaffolds and use this information to construct the genomic model of 
magnaHR97a and b. The genomic structure of magnaHR97a/b was analyzed in terms of 
position, length, and phase of each intron. We also compared the intronic parameters and 
protein sequence homology of the two receptors between D. magna and D. pulex using 
ClustalW (http://www.ebi.ac.uk/Tools/clustalw2/).   
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Expression plasmids: Chimeric plasmids containing the D, E (LBD), and F domains of 
the magnaHR97a (GAL4-97aDEF) and magnaHR97b (GAL4-97bDEF) receptor attached 
to the DNA binding domain (DBD) of Gal4 were assembled for the purpose of 
performing transactivation assays.  The chimeric plasmids were constructed using the 
Clontech In-Fusion Dry-Down PCR Cloning Kit (Clontech Laboratories, Mountain 
View, CA) as described previously (Chapter Two). Primers used in amplifying the D, E 
and F domains of the two receptors include: F-clonetech-97a-BamHI (5’- GAA TTC 
CCG GGG ATC GAT GAA CGC AAA GCC CTG ATG AAA GCA CGT -3’), R-
clonetech-97a-XbaI (5’- CTG CGG CCG CTC TAGA TCA TTG GAG CTT GTT GGT 
ATC TTT GGC TGG TCG -3’), F-clonetech-97b-BamHI (5’- GAA TTC CCG GGG 
ATC GAT GAA CGC AAA GCT TTA ATG AAA GCT CGA GC -3’), and R-clonetech-
97b-XbaI (5’- CTG CGG CCG CTC TAGA TCA GTG GGC GTC GTA AAG CTC 
TGA ATA TTC TTC -3’). The PCR products were inserted into the pBIND vector 
(Promega CheckMate Mammalian Two-hybrid system, Promega, Madison, WI) in frame 
after the GAL4 DNA binding domain. 
 
Transactivation Assays: HEPG2 human hepatoma cells (ATCC, Rockville MD) were 
used for transactivations. The cells were cultured in phenol red free Dulbecco’s Modified 
Eagle’s Medium (DMEM) (Mediatech, Manassas, VA) supplemented with 10% fetal 
bovine serum (HyClone, Logan, UT), 1% L-glutamine (Invitrogen, Carlsbad, CA) and 
1% Penicillin/Streptomycin (Invitrogen, Carlsbad, CA) at 37 °C under 5% CO2. 
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For transactivation assays HepG2 cells were plated in 12-well plates at 200,000 cells per 
well. Transfection was carried out the day after plating using Effectene Transfection 
Reagent (Qiagen, Valencia, CA) with 0.02 µg expression plasmid GAL4-97aDEF or 
GAL4-97bDEF and 0.1 µg the pG5luc (Promega, Madison, WI) reporter plasmid that 
contains five GAL4 binding sites upstream of the firefly luciferase gene. On the third day 
cells were either left untreated or treated with the chemicals of interest dissolved in 0.1% 
DMSO.  Control cells received 0.1% DMSO. Luciferase activity was measured as 
luminescence with the Steady-Glo Luciferase Assay System (Promega, Madison, WI) 24 
hours after chemical treatment. 
 
Results of the transactivation assays are presented as the mean of triplicate assays + 
standard error. Statistical analysis was carried out using GraphPad Prizm 4.0 statical and 
graphing package (La Jolla, CA). Statistical significance was determined by ANOVA 
followed by Dunnett’s test as the post hoc test. 
 
Phylogenetics:  
Phylogenetic analyses of HR97a and HR97b and the related receptors was performed 
using methods described previously (Hannas et al., 2010; Thomson et al., 2009) with 
some modification.  HR97a and HR97b from D. magna was compared to D. pulex and to 
receptors of other species available in GenBank such as Drosophila melanogaster, 
Xenopus laevis, Danio rerio, Homo sapiens, Ciona intestinalis, Ixodes scapularis, and 
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Caenorhabditis elegans. NCBI accession numbers for the receptors used are available in 
Appendix E. The DNA binding domain (DBD) and the ligand binding domain (LBD) of 
each receptor were identified using the conserved domain database (CDD) (Marchler-
Bauer et al., 2005). Zf-C4 (pfam00105) was used to identify the DBD and Hormone 
recep (pfam00104) was used to identify the LBD.  ClustalX default parameters were used 
to align the domains (Thompson, Gibson, Plewniak, Jeanmougin, & Higgins, 1997).    
 
Phylogenetic trees were were constructed using Bayesian Inference, Neighbor Joining, 
and Maximum Parsimony, and all other trees are compared to the Bayesian tree.  
Bayesian Inference was performed with MrBayes software version 3.1.2 (Ronquist & 
Huelsenbeck, 2003) on the Computational Biology Service Unit of Cornell University 
(http://cbsuapps.tc.cornell.edu/mrbayes.aspx).  Trees were constructed using the “mixed-
model” approach in which the Markov chain Monte Carlo sampler explores nine different 
fixed-rate amino acid substitution models implemented in MrBayes. We used 4 chains 
with runs of 5 million generations, chains sampled every 100 generations, a burnin of 
5,000 trees with the WAG model (Whelan & Goldman, 2001). CeNHR-1, a member of 
the NR1K group, was used as outgroup.   
 
Maximum Parsimony and distance parameters were used to provide additional support 
for the phylogenetic relationships observed. Distance parameters were measured using 
PAUP 4.0b10 (Swofford, 2001) with default characteristics (mean character difference 
and among site rate variation), and Neighbor-joining/UPGMA searches. Branch support 
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was measured by bootstrap analysis with 1000 replicates. Parsimony was constructed 
using PAUP version 4.0b10 with heuristic searches, tree-bisection-reconnection, 
topological constraints not enforced, and multiple tree option in effect with an initial 
maximum tree setting at 100,000. Branch support was measured by bootstrapping with 
50,000 replicates. FigTree (http://tree.bio.ed.ac.uk/software) was used to visualize the 
phylogenetic trees.   
 
 
RESULTS 
Genomic Structure 
After we cloned the magnaHR97a and HR97b genes using 5’- and 3’-RACE, we were 
able to blast them against the newest version of the D. magna genome project.  Similar to 
DappuHR97a and HR97b, these two genes are found in tandem repeat.  In addition, the 
position, length, and phase of each intron within the magnaHR97a and magnaHR97b 
genes was determined and compared to magnaHR97g and the HR97a and b receptors 
from Daphnia pulex (DappuHR97a/b) (Figure 3.1). There is not much species variation 
as to gene structure between D. magna and D. pulex. HR97a and HR97b have similar 
gene structures: both have two introns, and the phases of the first and second introns are 0 
and 1, respectively. This is different from HR7g that has three introns and of which the 
intron phases are 1, 2 and 2 from the first to the third intron respectively.  However, 
within the first exon of DappuHR97a, we found a possible intronic site from base pair 
426 to 506 that obeys the GT-AG rule. A potential intron site is also found in 
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magnaHR97a from base pair 416 to 514 (Figure 3.2).  The potential intron would make 
the gene structure of HR97a more similar to HR97g. The genomic structure of HR97a 
and HR97b further indicates that HR97g is the precursor of HR97a and HR97b. 
However, the alternative magnaHR97a and DappuHR97a does not share the same intron 
phases. 
 
In addition, the five domains of magnaHR97a and HR97b were aligned and compared to 
the corresponding domains in Fin-magnaHR97a/b and DappuHR97a/b (Table 3.1). Our 
D. magna sequences agree very well with the Finish strain of D. magna with only minor 
variances. The five domains of HR97a/b, especially the C and E domains, are very 
similar between D. magna and D. pulex with identity scores equal or close to 100. 
Alignment of the A/B domain of magnaHR97b and DappuHR97b produced the lowest 
identity score. This domain in magnaHR97b is shorter than DappuHR97b by 32 amino 
acids, meaning it is 36% shorter than the A/B domain of DappuHR97b. The identity 
score of the A/B domain of HR97a in both species is only 68, but it is mainly due to the 
difference in amino acid composition as opposed to the length. The F domain of each 
receptor varies in the two species both in length and amino acid composition. 
 
The five domains of magnaHR97a were also aligned with the corresponding domains of 
several other nuclear receptors including magnaHR97b, magnaHR96-Fin, DappuHR96, 
DmDHR96, HsCAR, magnaKNR-R1, magnaKNR-R2 and magnaRXR. MagnaHR97a is 
highly similar to magnaHR97b in the C and E domains, but not similar to other receptors, 
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including HR97g.  This suggests that HR97a and HR97b have different ligands and 
different response elements than HR97g.  
 
 
 
Figure 3.1 Gene structure of HR97a and HR97b in D. magna and D. pulex.  A) Gene 
structure of HR97a. B) Gene structure of HR97b. The blocks represent exons. The 
numbers represent the size of the exons and introns. Numbers in parentheses represent the 
intron phases.  
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Figure 3.2 Gene structure of alternative HR97a and comparison to HR97g.  A) Gene 
structure of alternative HR97a in D. magna and D. pulex. B) Gene structure of HR97g in 
D. magna and D. pulex. The blocks represent exons. The potential intron splits the first 
exon into two, which makes the gene structure of the alternative HR97a more similar to 
HR97g.  
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Table 3.1 Percent identitya of each domain when comparing the cloned HR97a and 
HR97b genes from the Clemson D. magna strain to HR97a and HR97b from the 
Finland D. magna strain (D. magna-Fin) and Daphnia pulex (Dappu).  
  
A:  HR97a 
 
B:  HR97b 
 A/B C D E F 
D. magna-Fin 98 98 98 100 98 
D. pulex 35 98 92 97 60 
aData shown as identity scores derived from ClustalW 
 
 
 
 
 
 
 
 
 
 A/B C D E F 
D. magna-Fin 97 100 100 97 99 
D. pulex 68 100 84 90 47 
 65 
Table 3.2 Percent identity of magnaHR97a (Clemson strain) to other NRs.  
 
NR A/B C D E F 
magnaHR97b 24 98 74 76 21 
magnaHR97g 20 63 31 40 8 
magnaHR96-Fin 12 48 20 29 33 
DappuHR96 12 48 23 29 33 
DmDHR96 25 44 14 25 33 
HsCAR 12 42 11 20 50 
magnaKNR-R1 2 44 11 N/A N/A 
magnaKNR-R2 2 44 10 N/A N/A 
magnaRXR 15 42 8 15 0 
 
aData shown as identity scores to magnaHR97a derived from ClustalW. 
Hs = Homo sapiens, Dm = Drosophila melanogaster, Dappu = Daphnia pulex, magna = 
D. magna 
 
 
 
Phylogenetics 
 
The DBD/LBD combined tree seperates the receptors into three clades—NR1L that 
contains the HR97s; NR1J that contains HR96s, CeNHR48, CeNHR8 and CeDAF12; 
NR1I that contains CAR, PXR and VDR (Figure 3.3). In this tree there is no 
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disagreement between the three programs Bayesian Inference, Maximum Parsimony and 
Neighbor-Joining. HR97s are more closely related to HR96s than to CAR, PXR and 
VDR. This tree further confirms that the HR97s constitute a distinct group and that the 
newly-discovered IsHR97 identified from mining the tick (Ixodes scapularis) genome is 
a member of the HR97s. The arachnid Ixodes is within the Chelicerata subphylum of 
Arthropoda (Regier et al., 2010). We speculate that there has been an HR97 receptor in 
the ancient arthropods and it was carried on to Ixodes. But for the Pancrustacea branch 
which contains both hexapods and crustaceans (Regier et al., 2010), the land-based 
hexapods which include insects lost HR97, while the aquatic branchiopod Daphnia kept 
it and eveutually developed three HR97 receptors. The tree indicates that the 
differentiation between HR97a/b/g occurred before the speciation of D. magna and D. 
pulex. The DBD/LBD tree also shows, in agreement with previous studies (Thomson et 
al., 2009), that HR97g is the precursor of HR97a and HR97b.  
 
The LBD tree agrees very well with the DBD/LBD combined tree with only minor 
differences between the programs (Appendix F). The DBD Bayesian tree segregates into 
three clades—the Knirps, the HR97s, and the third clade consists of the NR1J and NR1I 
groups and is not able to separate the two (Appendix G). The Knirps are not in the other 
two trees because they lack a LBD. The DBD tree disagrees with the other two trees in 
that it suggests that Daphnia HR97a and HR97b are more closely related to IsHR97 
rather than Daphnia HR97g, but overall evidence indicates that the DBD/LBD combined 
tree is more reliable. The DBD tree also fails to differentiate HR97a from HR97b, likely 
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due to the high level of similarity in the DBDs of the receptors. The Parsimony DBD tree, 
like the Bayesian tree, was not able to separate the NR1J and NR1I groups. The NJ DBD 
tree, though, segregates into four distinct clades: the Knirps, the HR97s, NR1J and NR1I. 
?
Figure 3.3 Phylogenetic analysis of the NR1L group and similar nuclear receptors. 
NRs from several different species were analyzed based on their C and E domains using 
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Bayesian Inference, Maximum Parsimony and Neighbor-Joining methods. CeNHR1 was 
chosen as the outgroup. We adoped the tree structure from Bayesian Inference. 
Probability values were provided from left to right as from Bayesian Inference, 
Maximum Parsimony and Neighbor-Joining respectively. An X indicates disagreement 
from the Bayesian tree. Abbreviation of species names are as follows: magna=Daphnia 
magna, Dappu=Daphnia pulex, Is=Ixodes scapularis, Ce=Caenorhabditis elegans, 
Dm=Drosophila melanogaster, Ci=Ciona intestinalis, Dr=Danio rerio, Hs=Homo 
sapiens, Xl=Xenopus laevis.  
?
?
HR97a/b basal regulation?
To examine the basal regulation of HR97a, we transfected HepG2 cells with the GAL4-
97a/bDEF chimeric expression plasmid and the reporter plasmid pG5luc. Control cells 
were transfected with 0.1 µg of the reporter plasmid pG5luc only. After treatment, the 
cells received no further treatment. The luciferase assay shows that HR97a is able to 
repress transcription in the absence of an activator which is similar to the activity of 
HR97g described in Chapter two (Figure 3.4). Next we transfected cells with increasing 
amounts of GAL4-97aDEF chimeric plasmid (0-0.08 ug) supplemented with empty 
pBIND-GAL4 vectors to make the total amount of pBIND plasmids 0.08 µg. With the 
exception of the 0.04 µg treatment, HR97a exerts greater repression at higher doses 
(Figure 3.5A). 
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The basal regulation of HR97b was tested in the same way as HR97a. However, the 
luciferase assay result shows that HR97b regulates transcription in a very different 
manner comparing to HR97a and HR97g: it induces transcription when unbound (Figure 
3.4). In the dose response study of HR97b, the presence of empty pBIND-GAL4 vectors 
seemed to repress the activity of GAL4-97bDEF (Figure 3.5B). So we did another assay 
with different doses of GAL4-97bDEF but without empty pBIND-GAL4 vectors. The 
result shows that HR97b up-regulates transcription in the absence of activators with the 
maximal activation at 0.02 µg (Figure 3.5C).  
 
 
 
 
Figure 3.4 Basal activity of the HR97 receptors. Cells were transfected with 0.02 µg 
GAL4-97a/b/gDEF chimeric plasmid and 0.1 µg reporter plasmid pG5luc. Control cells 
were transfected with 0.1 µg reporter plasmid pG5luc only. HR97a and HR97g repress 
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transcription in the absence of an activator. HR97b significantly up-regulates 
transcription (3-fold). Statistical significance was determined using GraphPad Prizm 4.0 
statistical and graphing package (La Jolla, CA).   
 
 
 
Figure 3.5 Dose response studies of HR97a/b basal regulation. A) Cells were 
transfected with 0, 0.01, 0.02, 0.04 and 0.08 µg GAL4-97a DEF chimeric plasmid 
supplemented with empty pBIND-GAL4 vectors to make the total amount of pBIND 
plasmids 0.08ug. Except for the 0.04 µg treatment, HR97a exerts greater repression at 
higher doses. B) Cells were transfected with 0, 0.01, 0.02, 0.04 and 0.08 µg GAL4-97b 
DEF chimeric plasmid supplemented with empty pBIND-GAL4 vectors to make the total 
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amount of pBIND plasmids 0.08 µg . Empty pBIND-GAL4 vectors repress the activity of 
GAL4-97bDEF. C) Cells were transfected with 0, 0.02, 0.04 and 0.08 µg GAL4-97a DEF 
chimeric plasmid without adding empty pBIND-GAL4 vectors. HR97b up-regulates 
transcription with the maximal activation at 0.02 µg in the absence of activators.  
 
 
Chemical screening and pyriproxyfen activation: 
HepG2 cells were transfected with GAL4-97gDEF chimeric plasmid and the reporter 
plasmid pG5luc to determine the potential HR97a and HR97b activators. The next day 
cells were treated with chemicals at 10 µM, control cells were treated with 0.1% DMSO. 
None of the chemicals tested activated HR97a or HR97b (Figure 3.6). Next, we treated 
cells with pyriproxyfen and methyl farnesoate at 10 µM, as these two chemicals have 
been discovered to activate HR97g, another member of the NR1L group and the 
evolutionary precursor of HR97a/b. The luciferase assay shows that pyriproxyfen 
significantly activates HR97a but the activation for HR97b was not statistically 
significant (Figure 3.7 A B). We subsequently repeated the pyriproxyfen treatment at 
both 3 µM and 10 µM. This time pyriproxyfen significantly activates HR97b at 10 µM 
(Figure 3.7 D). However, this time although HR97a was activated in a dose-dependent 
manner, the activation was not statistically significant (Figure 3.7 C). In all, pyriproxyfen 
may be a weak activator for both HR97a and HR97b, but is unlikely a potent activator. 
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Figure 3.6 HR97a/b multi-chemical tests. Cells transfected with GAL4-97aDEF(A) or 
GAL4-97bDEF (B) and pG5luc were treated with different chemicals at 10 uM. Control 
cells were treated with 0.1% DMSO. Parathion and 4-nonylphenol caused some cell 
death in the 97a treatment. None of the chemicals activates either receptor. 
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Figure 3.7 Pyriproxyfen and methyl farnesoate test. A) HR97a tansactivation. Cells 
transfected with GAL4-97aDEF and pG5luc were treated with pyriproxyfen and methyl 
farnesoate at 10 uM. Control cells were treated with 0.1% DMSO. B) HR97b 
tansactivation. Cells transfected with GAL4-97bDEF and pG5luc were treated with 
pyriproxyfen and methyl farnesoate at 10 uM. C) HR97a pyriproxyfen two-dose test. 
Cells were treated with pyriproxyfen at 3 uM and 10uM after transfection with GAL4-
97aDEF and pG5luc. D) HR97b pyriproxyfen two-dose test. Cells were treated with 
pyriproxyfen at 3 uM and 10uM after transfection with GAL4-97bDEF and pG5luc. 
Pyriproxyfen has weak activation for both receptors at 10 uM. 
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DISCUSSION 
The evident difference in the regulatory functions of magnaHR97a and magnaHR97b 
provides further evidence that closely related nuclear receptors could develop different 
roles through changes in amino acid composition during evolution. Without activators 
HR97a functions as a repressor, while HR97b constitutively up-regulates transcription. 
The relationship between the two is very much like CAR and PXR, two closely related 
receptors in the NR1I group. PXR represses gene expression in the absence of ligands 
(Hernandez et al., 2009; Takeshita et al., 2002). HR97a, like PXR, is likely to recruit co-
repressors such as N-CoR (nuclear receptor corepressor) and SMRT (silencing mediator 
for retinoid and thyroid hormone receptors) when unliganded. Ligand binding causes the 
release of the co-repressors and recruits coactivators (Larsen et all, 2002), which is 
probably why we see the increased activity when we treat cells with pyriproxyfen. On the 
other hand, HR97b functions like CAR that has been proven to have constitutive activity 
(Baes et al., 1994). The constitutive activity of CAR has been attributed to its unique 
structure that orients the AF-2 helix in the active position (Xu et al., 2004). It is possible 
that HR97b has a similar structure that could be used to explain its constitutive activity. 
 
In addition, this study provides additional evidence that the LBD of a receptor is not only 
crucial in functions beyond ligand-binding, but also in its distinct activation functions. 
There are two motifs in a nuclear receptor that are involved in the recruitment of 
coactivators—AF-1 in the A/B domain and AF-2 in the LBD (Thomson et al., 2009). 
Since the A/B domain of the HR97a/b is not included in our chimeric plasmids, the 
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difference in the functions of the receptors shown by the transactivations in the absence 
of activators is mostly likely attributed to the AF-2 motif within the LBD.  
 
ClustalW alignment shows that HR97a and HR97b share high similarity in all five 
domains. They are almost identical in the DNA binding domain, indicating that they 
might regulate the same genes. Both HR97a and HR97b are activated by pyriproxyfen, 
like their evolutionary precursor HR97g (Chapter Two). However, contrary to HR97g, 
they are not activated by MF. The ligand binding domains of HR97a and HR97b are not 
similar to that of HR97g, meaning the ligand binding pockets in the LBDs of the 
receptors have different structures, which could explain the different results from 
transactivations.  
 
The phylogenetic tree confirms that HR97a and HR97b are most closely related and less 
ancestral than HR97g, agreeing with previous discovery that HR97g is the evolutionary 
precursor to HR97a and HR97b, which are in tandem repeat (Thomson et al., 2009). The 
phylogenetic tree also puts IsHR97 in the same clade with the HR97s from Daphnia. 
 
NR1L is related to the NR1J and NR1I groups. Although CAR and PXR in the NR1I 
group as well as HR96 in the NR1J group have been shown to be promiscuous receptors 
activated by many chemicals (Hernandez et al., 2009; King-Jones et al., 2006), this study 
and our previous study (Chapter Two) showed that HR97s are not promiscuous receptors.  
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Furthermore, recent data our research group obtained demonstrated that Daphnia HR96 is 
promiscuous.   
 
In addition, not all receptors related to the HR97s are promiscuous chemical sensors. The 
NR1J member DAF-12 in C. elegans, for example, has been shown to regulate dauer 
diapause and development (Antebi et al., 2000). The NR0A members KNI and KNRL, 
closely related to the HR97s in the DBD only tree, regulate the development of the 
second wing vein in Drosophila (Lunde et al., 1998). The juvenile hormone analog 
pyriproxyfen has been shown to induce male production, which is the first step of 
Daphnia’s defense mechanism against harsh environment, a mechanism that serves the 
similar purpose as dauer diapause in C. elegans, as the male Daphnia will turn the 
population from parthenogenetic reproduction into sexual reproduction. And the eggs 
from sexual reproduction will go into a diapause until the environmental conditions get 
better (Tatarazako & Oda, 2007). The fact that HR97a and b are activated by 
pyriproxyfen would suggest a putative role in juvenile hormone functions, except the 
endogenous Daphnia juvenile hormone methyl farnesoate did not activate HR97a or 
HR97b in this study. It is possible that these receptors need to pair with a partner receptor 
in order to have greater activation. 
 
In summary, HR97a/b/g developed from one ancient HR97 receptor that was amplified 
into three receptors before the speciation of D. magna and D. pulex. HR97a functions as a 
repressor in the absence of an activator while HR97b is a constitutive activator. HR97a 
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and b are activated by pyriproxyfen and we hypothesize that they are involved in 
development based on their low promiscuity and their phylogenetic relationship to the 
NR0A and NR1J receptors. 
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CHAPTER FOUR 
 
CONCLUSION 
 
This study is a partial characterization of the NR1L group that was initially identified in 
Daphnia pulex. The study proved the existence of HR97g, HR97a, and HR97b in 
Daphnia magna, and verified that the three receptors do form a distinct group (NR1L) in 
the NR1 subfamily of nuclear receptors. This group was first found in the crustacean 
Daphnia pulex, however our study showed that Ixodes scapularis also have a receptor 
(IsHR97) that can be phylogenetically positioned in this group. The NR1L group is 
related to the NR1J group that contains HR96 (Thomson et. al., 2009), which in turn is 
related to the NR1I group that contains CAR, PXR, and VDR (Lin, Kozaki, & Scott, 
2010).  In searching for the activators for the three receptors, we had set up two 
objectives: 
 
Objective 1: Cloning, sequencing, and characterization of magnaHR97g. 
We successfully cloned and sequenced magnaHR97g. We analyzed the gene structure of 
HR97g in terms of position, length, and phase of each intron. Also, we aligned the 
sequence of magnaHR97g to similar receptors and conducted phylogenetic studies to 
study the events during evolution of HR97g and related receptors. To search for the 
activators for magnaHR97g, we constructed the chimeric plasmid GAL4-97gDEF. We 
found that HR97g functions as a repressor when in the absence of activators, but in the 
presence of pyriproxyfen or methyl farnesoate it induces transcription.  
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Objective 2:  Cloning, sequencing, and characterization of magnaHR97a and 
HR97b. 
We cloned and sequenced magnaHR97a and HR97b. We analyzed their gene structures 
and compared them to magnaHR97g. Both HR97a and HR97b only have 3 exons, 
however, within the first exon of HR97a, we found a possible intronic site that obeys the 
GT-AG rule, which could make HR97a more similar to HR97g that has 4 exons. We 
aligned the five domains of magnaHR97a to similar receptors and conducted 
phylogenetic studies to study the events during evolution of the HR97s and related 
receptors. To search for the activators for magnaHR97a and b, we constructed the 
chimeric plasmids GAL4-97a/bDEF. We found that HR97a, same as HR97g, functions as 
a repressor when in the absence of activators, but HR97b constitutively activates 
transcription. Both magnaHR97a and HR97b are activated by pyriproxyfen, but the effect 
is not consistently strong.  
 
Pyriproxyfen is a juvenile hormone analog that has been shown to induce male broods 
with very high potency (Olmstead & Leblanc, 2002; Tatarazako, Oda, Watanabe, Morita, 
& Iguchi, 2003). MF, the unepoxidated form of insect JH III, also induces the production 
of male broods in Daphnia magna (Olmstead & Leblanc, 2002). Since we discovered that 
pyriproxyfen activates all three HR97 receptors and that MF activates HR97g, it is 
interesting to further investigate whether the HR97s are involved in Daphnia male 
production. According to my labmate Gautam Ginjupalli’s data, magnaHR97g is 
primarily expressed in the mandibular organs, ovaries, and gut, and is expressed more in 
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reproductively active adults. This further supports our hypothesis that HR97g is involved 
in Daphnia responding to environmental signals including food (gut) and altering to 
sexual reproduction (ovaries) under the regulation of MF (produced by the mandibular 
organ).  
 
Switching from parthenogenic cloning of females to the production of males for sexual 
reproduction is a protective mechanism for Daphnia in response to many different 
environmental signals such as short day length, food shortage, and high population 
density (Tatarazako & Oda, 2007), as the ephippial eggs from sexual reproduction can 
survive through harsh conditions. Juvenile hormones are believed to be involved in this 
process as they induce the production of males at nanomolar concentrations (Olmstead & 
Leblanc, 2002). We speculate that instead of one single JH receptor, Daphnia might have 
multiple JH receptors with different functions.  Similarly there are multiple retinoic acid 
binding receptors in mammals (Chambon, 1996). 
 
We hypothesize that one or more of the HR97s are involved in the JH regulated male 
production. But it is possible that similar to PXR, which interacts with itself and RXR to 
recruit co-activators such as SRC-1 (Carnahan & Redinbo, 2005; Noble et al., 2006), 
HR97s may interact with RXR or other receptors that allow them to recruit co-activators 
and achieve greater activation. Future work should investigate the receptors’ interactions 
with RXR and co-activators. For example, transactivations can be performed in the 
presence of RXR and SRC-1. Considering the repressive and constitutive functions of 
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HR97a and HR97b, future work should also investigate whether these receptors interact 
with each other. 
 
Since food-shortage could cause male production in Daphnia (Tatarazako&Oda, 2007), it 
is interesting to see the effect of dietary fatty acids on the HR97s. Our preliminary data 
showed that the long chain polyunsaturated fatty acid (PUFA) arachidonic acid represses 
the activity of all HR97s (data not shown). If one or more of the HR97s is a JH receptor, 
the repression of HR97g by arachidonic acid in live daphnids could prevent the 
production of males when food is abundant. It has been shown that absence of long chain 
PUFAs limits egg production of Daphnia magna (Martin-Creuzburg & Elert, 2009), 
suggesting that PUFAs have some role in development.  
 
MagnaHR97g and magnaHR97a repress transcription when in the absence of activators 
while HR97b constitutively activates transcription.  Opposing regulatory functions 
between closely related receptors in the absence of activators have been observed for 
CAR and PXR, both NR1I members. PXR represses gene expression in the absence of 
ligands (Hernandez, Mota, & Baldwin, 2009; Takeshita et. al., 2002) by binding the co-
repressors N-CoR or SMRT. CAR is constitutively active, but held in the cytosol so it 
does not have significant activity in vivo.  Activation causes the loss of CAR cytosolic 
retention protein (CCRP) and allows for translocation to the nucleus (Kobayashi et. al., 
2003).  However, because CCRP and other cytosolic retention proteins are not expressed 
in most immortal cell lines, CAR is constitutively active in HepG2 cells (Baldwin & 
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Roling, 2009; Kawamoto et al., 1999; Kobayashi et al., 2003). It is possible that during 
evolution HR97a has retained the structure of its precusor HR97g, which facilitates the 
recruitment of co-repressors while HR97b, through subtle tinkering, adopted a structure 
that is more like CAR that allows constitutive activity. It would be worthwhile to perform 
parallel studies using another cell line such as an insect cell line. 
 
Another subsequent study for the HR97s should be aimed at their possible interactions 
with each other. We have cloned the full-length magnaHR97a, magnaHR97b, and 
magnaHR97g into the mammalian expression plasmid pACT (Promega CheckMate 
Mammalian Two-hybrid system, Promega, Madison, WI). In our next set of 
transactivation assays we will co-transfect HepG2 cells with pBIND-GAL4-97a/b/gDEF 
plasmids, or pBIND-GAL4-RXRpaired with the pACT plasmids expressing the full-
length magnaHR97a/b/g to see if there is any interaction between the receptors that 
affects transcriptional regulation in the presence of activators.  This assay is a modified 
mammalian two-hybrid assay called a co-activator or co-partner dependent receptor 
ligand assay (CARLA).  Preliminary studies using dual pBIND plasmids suggest that 
HR97a and HR97b work together, but the assay also allowed for GAL4 competition at 
the response element. Using the pACT system will eliminate this obstacle. 
 
We had hypothesized that HR97s are xenobiotic receptors that are activated by multiple 
toxicants because it is found in the same nuclear receptor clade as HR96, CAR, and PXR, 
all of which are xenosensors. However in our transactivation assays only juvenile 
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hormone analogs activated them. In addition, ClustalW alignments showed little 
similarity between HR97s and Fin-magnaHR96, DmDHR96, CeDAF12 or HsCAR. So 
we conclude that HR97s might not be xenobiotic sensors like the NR1I and NR1J 
receptors, and we hypothesize that they are receptors involved in development.  
 
To further prove that HR97g is a JH receptor, we could try to purify the receptor from 
Daphnia and determine the native ligand bound to the receptor (provided that there is 
one). A binding assay could also be performed using radio labeled putative ligands. 
 
It would greatly help the characterization of the HR97s if RNAi technology is available. 
Although RNAi has only been used in developing Daphnia embryos (Kato et al., 2011), 
it is beyond doubt worthwhile to try this technology in reproductive adults. Knocking 
down the HR97s would conveniently reveal the physiological functions related to the 
receptors, though it will require other studies to differentiate the direct functions from 
indirection functions. With the sequences of the three HR97 receptors available and 
putative activators found, it would also be interesting to see what genes are regulated by 
the HR97s. A ChIP assay can be conducted to find the response elements these receptors 
bind to; hence the genes directly regulated by them can be recognized.  
 
This study alone is not going to solve the puzzle of environmental sex determination. 
However, it contributes to the sea of studies on this question. If our subsequent studies 
prove that HR97g is a JHA receptor, the Gal4-97gDEF plasmid can be used as a 
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detection system to screen potential male inducers from other environmental chemicals 
and help protect our ecosystems. But for now, this study at least adds to our 
understanding of a new branch in the enormous tree of nuclear receptors that was only a 
seedling in 1985. 
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Appendix A 
Nuclear receptors used in phylogenetic analysis 
 
aNC-IUPHAR  Receptor Species (common name)             GenBank Accession No.  
0A DappuKNR-R1 Daphnia pulex (D. pulex) EFX76945.1 
0A DappuKNR-R2 Daphnia pulex (D. pulex) EFX76947.1 
0A KNI D. melanogaster (fruitfly) CAA31709 
0A KNRL D. melanogaster (fruitfly) AAF51627 
0A EGON D. melanogaster (fruitfly) CAA34626 
1H magnaEcR D. magna ABP48741 
1I VDR H. sapiens (Human) AAB95155 
1I PXR H. sapiens (Human) AAD05436 
1I PXR Danio rerio NP_001092087 
1I CAR H. sapiens (Human) AAY56401 
1I VDRL Ciona intestinalis NP_001071847 
1J DappuHR96 Daphnia pulex (D. pulex) EFX89804.1 
1J DHR96 D. melanogaster (fruitfly) AAC46928 
1J DAF-12  Caenorhabditis elegans(C. elegans) AAD34462 
1J NHR-8 Caenorhabditis elegans(C. elegans) AAP31437 
1J NHR-48 Caenorhabditis elegans(C. elegans) CAD36502 
1L DappuHR97a Daphnia pulex (D. pulex) EFX79885.1 
1L DappuHR97b Daphnia pulex (D. pulex) 442724b 
1L DappuHR97g Daphnia pulex (D. pulex) EFX77588.1 
1L magnaHR97g D. magna JF792806 
b For DappuHR97b, the JGI genome portal version 1.1 protein identification number is provided. 
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Appendix B 
Phylogenetic Comparison of NR1I/J/L/0A Nuclear Receptors Using Only Their DBDs 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Probability values were provided from left to right as from Bayesian Inference, Neighbor-Joining and 
Maximum Parsimony respectively. An X indicates disagreement from the Bayesian tree.  
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Appendix C 
Phylogenetic Comparison of NR1I/J/L Nuclear Receptors Using Only Their LBDs  
 
 
Probability values were provided from left to right as from Bayesian Inference, Neighbor-Joining and 
Maximum Parsimony respectively. An X indicates disagreement from the Bayesian tree.  
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Appendix D 
ClustalX Alignment File Comparing the Sequences of MagnaHR97g and DappuHR97g 
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Appendix E 
HR97a/b Phylogenetics Accession Numbers 
aNC-IUPHAR  Receptor Species (common name) Accession No.  
1I VDR Xenopus laevis NP_001079288 
1I VDR Danio rerio AAI62226 
1I VDR Danio rerio NP_001153457 
1I PXR   H. sapiens (Human) AAD05436 
1I PXR Danio rerio NP_001092087 
1I PXR Xenopus laevis CAA53006 
1I PXR Xenopus laevis NP_001083606 
1I CAR   H. sapiens (Human) AAY56401 
1I VDRL Ciona intestinalis NP_001071847 
1J HR96 Daphnia pulex (D. pulex) EFX89804.1 
1J HR96 Daphnia magna  
1J HR96 Ixodes scapularis XP_002404556 
1J DHR96 D. melanogaster (fruitfly) AAC46928 
1J DAF-12  
Caenorhabditis elegans 
(C. elegans) AAD34462 
1J NHR-8 
Caenorhabditis elegans 
(C. elegans) AAP31437 
1J NHR-48 
Caenorhabditis elegans 
(C. elegans) CAD36502 
1B SmHR96L Schistosoma mansoni XP_002575014 
1K NHR-1 
Caenorhabditis elegans 
(C. elegans) AAC48174 
1L HR97a Daphnia pulex (D. pulex) EFX79885.1 
1L HR97a Daphnia magna AUGep24b_p1s02190g158t1 
1L HR97b Daphnia pulex (D. pulex) 442724b 
1L HR97b Daphnia magna AUGep24b_p1s02190g159t1 
1L HR97g Daphnia pulex (D. pulex) EFX77588.1 
1L HR97g Daphnia magna JF792806 
1L HR97 Ixodes scapularis XP_002402961 
0A DpKNR-R1 Daphnia pulex (D. pulex) 
EFX76945.1 
0A KNR-R1 Daphnia magna  
0A DpKNR-R2 Daphnia pulex (D. pulex) EFX76947.1 
0A KNR-R2 Daphnia magna  
0A KNI D. melanogaster (fruitfly) CAA31709 
0A KNRL D. melanogaster (fruitfly) AAF51627 
0A EGON D. melanogaster (fruitfly) CAA34626 
2B RXR Daphnia magna  
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Appendix F 
HR97a/b Phylogenetic Comparison of NR1I/J/L Nuclear Receptors Using Only LBDs 
 
 
Probability values were provided from left to right as from Bayesian Inference, Maximum Parsimony 
and Neighbor-Joining respectively. An X indicates disagreement from the Bayesian tree.  
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Appendix G 
HR97a/b Phylogenetic Comparison of of NR1I/J/L/0A Nuclear Receptors Using DBDs 
 
Probability values were provided from left to right as from Bayesian Inference, Maximum Parsimony 
and Neighbor-Joining respectively. An X indicates disagreement from the Bayesian tree.  
 
